TCL Archive FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds February 19, 2010
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture November 2, 1990